Biologic Excipients Market, By Product (Solubilizers, Stabilizers, Preservatives, Buffers, and3 Carriers), By Source, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Biologic Excipients Market size was valued at US$ 2,983.43 Million in 2024, expanding at a CAGR of 5.90% from 2025 to 2032.
Biologic excipients are inactive components used in the formulation of biologic drugs to enhance their stability, solubility, and overall performance. Unlike active pharmaceutical ingredients (APIs), these excipients do not provide therapeutic effects but play a vital role in maintaining the efficacy, safety, and shelf-life of biologic products. Given the fragile nature of biologics such as proteins, peptides, and monoclonal antibodies, selecting suitable excipients is essential for addressing challenges related to stability, degradation, and drug delivery.
Due to their complex structures, biologic molecules are highly susceptible to environmental factors such as heat, light, and pH fluctuations. Excipients function as stabilizers, preventing protein aggregation, oxidation, and denaturation, thereby preserving the drug’s potency. Additionally, solubilizers and surfactants enhance the solubility of poorly soluble compounds, improving their bioavailability and therapeutic effectiveness. Preservatives and buffering agents help maintain sterility and pH balance, ensuring the safe administration of the drug to patients. The significance of biologic excipients lies in their ability to optimize drug formulation, support large-scale production, and extend shelf-life while maintaining product quality. Their proper use contributes to improved patient outcomes, regulatory compliance, and the commercial success of biologic therapies in modern medicine.
Biologic Excipients Market- Market Dynamics
Increasing demand for biologic drugs
The growing demand for biologic drugs is a major factor driving the expansion of the biologic excipients market. Biologics, known for their targeted and highly effective treatments, are widely used in managing complex diseases such as cancer, autoimmune disorders, and rare genetic conditions. These drugs, including monoclonal antibodies, vaccines, and cell therapies, have intricate molecular structures and are highly sensitive to environmental factors, necessitating specialized excipients to ensure their stability, efficacy, and safety.
This rising demand is further fueled by the increasing prevalence of chronic diseases worldwide and the growing geriatric population in need of advanced therapeutic solutions. According to the World Health Organization (WHO), chronic diseases contribute to approximately 71% of global deaths, underscoring the urgent need for innovative biologic treatments. In response, governments and healthcare organizations are ramping up investments in biologic drug research and development. In the United States, for example, biologics accounted for nearly 50% of the top 100 prescription drug sales in 2023, highlighting their market dominance.
As biologic drug manufacturers seek advanced excipient solutions to optimize formulation and drug delivery, the demand for biologic excipients continues to rise. This trend is expected to drive significant market growth, supported by ongoing innovations in biologic therapies and the need to meet stringent regulatory and quality standards.
Biologic Excipients Market- Segmentation Analysis:
The Global Biologic Excipients Market is segmented based on Product, Source, Application, and Region.
Product Segmentation
The market is categorized into five key product types: Solubilizers, Stabilizers, Preservatives, Buffers, and Carriers. Among these, Stabilizers hold the largest market share due to their essential role in preventing protein aggregation, oxidation, and denaturation—common challenges associated with biologic drugs. Their ability to enhance drug stability and extend shelf life makes them indispensable in biologic formulations.
Application Segmentation
By application, the market is classified into Biopharmaceutical Production, Research and Development, and Clinical Trials. Biopharmaceutical Production dominates this segment, as it represents the largest and most critical application area. The need for specialized excipients in large-scale manufacturing ensures the stability, efficacy, and scalability of biologic drugs. The rising demand for innovative biologic therapies and the increasing need for efficient production processes further drive the extensive use of excipients in this sector.
Biologic Excipients Market- Geographical Insights
North America: Market Leader
North America dominates the biologic excipients market, primarily due to its well-established pharmaceutical and biotechnology industries, significant R&D investments, and the rising prevalence of chronic diseases that require biologic therapies. The United States holds a substantial market share, driven by major industry players, advanced research facilities, and favorable government initiatives. Regulatory support, such as the U.S. FDA’s fast-track approvals for biologics, further accelerates market growth.
Europe: Strong Biopharmaceutical Presence
Europe represents another major regional market, supported by robust biopharmaceutical production capabilities, innovation in drug development, and favorable regulatory policies from agencies like the European Medicines Agency (EMA). Countries including Germany, France, and the UK lead the region in biologic drug development and manufacturing, contributing to steady market growth.
Asia-Pacific: Fastest-Growing Region
The Asia-Pacific region is poised for the fastest growth, driven by an expanding pharmaceutical manufacturing sector, increasing investments in biologic R&D, and rising healthcare expenditures. Countries like China and India are emerging as key players, with government-backed initiatives to boost local biologic production and exports. Additionally, growing awareness of advanced therapies and the increasing presence of contract manufacturing organizations (CMOs) further contribute to regional market expansion.
Biologic Excipients Market- Competitive Landscape:
The Biologic Excipients Market is highly competitive, driven by continuous innovation, technological advancements, and an increasing demand for high-quality, specialized excipients designed for complex biologic formulations. Market players differentiate themselves through diverse product portfolios, offering stabilizers, solubilizers, and preservatives that comply with stringent regulatory requirements for biopharmaceutical applications. A key competitive strategy involves the development of multifunctional excipients with enhanced stability and improved biocompatibility.
Partnerships, collaborations, and strategic alliances between excipient manufacturers and biopharmaceutical companies are common, fostering customized solutions and joint innovation. Additionally, the growing trend of outsourcing biologic drug manufacturing has created significant opportunities for contract research and manufacturing organizations (CROs and CMOs), further intensifying market dynamics.
Companies are also expanding their geographic presence to leverage the rapid growth in emerging markets, particularly in the Asia-Pacific region. Innovation in sustainable and eco-friendly excipient production, driven by regulatory pressures and environmental concerns, is becoming a key differentiator. Furthermore, investments in advanced research facilities and strict adherence to evolving regulatory guidelines enhance competitive positioning within the industry.
Recent Developments:
July 2024: Agilent Technologies Inc. announced a definitive agreement to acquire BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO), for $925 million. This strategic acquisition aims to strengthen Agilent\'s biopharma solutions by integrating BIOVECTRA’s expertise in biologics, highly potent active pharmaceutical ingredients, and other specialized therapeutic molecules.
November 2024: Clariant unveiled a new range of high-performance excipients at CPHI India 2024 to cater to the evolving needs of the Indian healthcare sector. Designed for sensitive active pharmaceutical ingredients (APIs), parenteral formulations, and colorless applications, these excipients prioritize purity and bioavailability. By leveraging India\'s robust manufacturing capabilities, Clariant delivers customized solutions that adhere to global regulatory standards, ensuring the efficacy and safety of biologics and complex drug formulations.
October 2024: Samsung Biologics introduced a high-concentration formulation platform to enhance the development of high-dose biologic drugs. This platform is engineered to improve drug delivery and efficacy at higher concentrations, optimizing the development process to meet the rising demand for such therapies. It supports both the manufacturing and formulation of biologics, ensuring greater stability and scalability.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOLOGIC EXCIPIENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Dow Chemical Company
BASF SE
Evonik Industries AG
Lonza Group
Wacker Chemie AG
Asahi Kasei Corporation
Clariant International Ltd.
Croda International Plc
Ingredion Incorporated
Fuji Chemical Industry Co. Ltd.
Nippon Fine Chemical Co. Ltd.
DSM Nutritional Products
Protex International
Lubrizol Corporation
Ashland Global Holdings Inc.
Others
GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
Solubilizers
Stabilizers
Preservatives
Buffers
Carriers
Others
GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY SOURCE - MARKET ANALYSIS, 2019 - 2032
Animal-derived
Human-derived
Microbial-derived
Synthetic
GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Biopharmaceutical Production
Research and Development
Clinical Trials
GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o U.S.
o Canada
Europe
o Germany
o UK
o France
o Italy
o Spain
o The Netherlands
o Sweden
o Russia
o Poland
o Rest of Europe
Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o Indonesia
o Thailand
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o UAE
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
\"
TABLE OF CONTENT
1. Biologic Excipients Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Biologic Excipients Market Snippet by Product
2.1.2. Biologic Excipients Market Snippet by Source
2.1.3. Biologic Excipients Market Snippet by Application
2.1.4. Biologic Excipients Market Snippet by Country
2.1.5. Biologic Excipients Market Snippet by Region
2.2. Competitive Insights
3. Biologic Excipients Key Market Trends
3.1. Biologic Excipients Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Biologic Excipients Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Biologic Excipients Market Opportunities
3.4. Biologic Excipients Market Future Trends
4. Biologic Excipients Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Biologic Excipients Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Biologic Excipients Market Landscape
6.1. Biologic Excipients Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Biologic Excipients Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Solubilizers
7.1.3. Stabilizers
7.1.4. Preservatives
7.1.5. Buffers
7.1.6. Carriers
7.1.7. Others
8. Biologic Excipients Market – By Source
8.1. Overview
8.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
8.1.2. Animal-derived
8.1.3. Human-derived
8.1.4. Microbial-derived
8.1.5. Synthetic
9. Biologic Excipients Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Biopharmaceutical Production
9.1.3. Research and Development
9.1.4. Clinical Trials
10. Biologic Excipients Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Biologic Excipients Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Biologic Excipients Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Biologic Excipients Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Biologic Excipients Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Biologic Excipients Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Biologic Excipients Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Dow Chemical Company
11.2.2. BASF SE
11.2.3. Evonik Industries AG
11.2.4. Lonza Group
11.2.5. Wacker Chemie AG
11.2.6. Asahi Kasei Corporation
11.2.7. Clariant International Ltd.
11.2.8. Croda International Plc
11.2.9. Ingredion Incorporated
11.2.10. Fuji Chemical Industry Co. Ltd.
11.2.11. Nippon Fine Chemical Co. Ltd.
11.2.12. DSM Nutritional Products
11.2.13. Protex International
11.2.14. Lubrizol Corporation
11.2.15. Ashland Global Holdings Inc.
11.2.16. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
